13F

Stock

Corvus Pharmaceuticals, Inc.

CRVS · held by 2 managers

Reported value

$329.1K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$180.6K

Price effect on 1 books still in the name

Largest holder

$264.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC83.2K$264.7K−$180.6KCut−$302.5K
Leonteq Securities AG20K$64.4KNew

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.